The cognitive dissonance of prescribing narcotics

Note: The headline uses the everyday word “narcotics,” but in modern clinical practice the conversation is usually about opioid pain medicines.

Prescribing opioids can make even experienced clinicians feel like they are walking a tightrope in dress shoes during a windstorm. On one side is the duty to relieve pain, which is one of the oldest jobs in medicine. On the other side is the duty to avoid causing harm, which is also one of the oldest jobs in medicine. Both duties are real. Both are urgent. And when they collide in the same exam room, the result is something that looks a lot like cognitive dissonance with a stethoscope.

That dissonance is not just a philosophical problem for ethics seminars and hospital conference rooms with stale muffins. It shows up in daily clinical decisions: whether to write the first prescription, whether to continue a long-term refill, whether to taper, whether to trust the patient’s report of pain, whether to worry about scrutiny from regulators, and whether withholding medication might harm the very person a clinician is trying to protect. This is why prescribing opioids can feel less like straightforward medicine and more like emotional Sudoku.

At the center of the conflict is a basic truth: opioids can help. They can also hurt. Pretending either half of that sentence is not true is how bad policy, bad care, and bad conversations begin.

Why opioid prescribing creates cognitive dissonance

The clinician’s first instinct is to relieve suffering

When a patient arrives in obvious pain, the moral pull is immediate. Pain disrupts sleep, movement, work, family life, mood, and dignity. A surgeon may see a patient after a major procedure. A primary care physician may see someone with a spinal injury, severe arthritis, or cancer-related pain history. A hospitalist may hear a patient say, “I haven’t slept in three days.” In these moments, withholding relief can feel cold, detached, and even cruel.

That instinct is not weakness. It is the humane core of medical practice. Clinicians are not machines built to recite protocols while ignoring suffering. They are trained to respond to it. The trouble is that opioids offer a form of relief that can be fast, powerful, and deceptively reassuring. A short-term solution can feel like proof that the long-term plan is sound, even when the long-term evidence is less comforting.

The clinician’s second instinct is to prevent harm

This is where the mental friction begins. Opioids can reduce pain, but they also carry well-established risks: tolerance, physical dependence, misuse, opioid use disorder, overdose, dangerous interactions with sedatives, accidental exposure in the home, and the broader public-health consequences of excess supply. The prescription pad, in other words, is not a magic wand. Sometimes it is more like a fire extinguisher that also leaks gasoline if handled carelessly.

So the prescriber holds two ideas at once: “This patient may genuinely need relief” and “This medication may create a new layer of risk.” Both can be true. In fact, they often are. Cognitive dissonance enters when the clinician is forced to act as though the answer should be simple when it is anything but.

The evidence makes the tension sharper, not simpler

For acute pain, opioids may have a role

In acute pain settings, opioids can still be appropriate. After certain surgeries, severe injuries, or brief episodes of intense pain, a carefully chosen short course may help patients function, rest, and recover. That is the part of the conversation that sometimes gets lost in the culture war around opioids: no serious clinician thinks every opioid prescription is automatically reckless. Medicine is not served by absolutism wearing a lab coat.

But even here, the modern approach is more restrained than it once was. Clinicians are encouraged to use the lowest effective dose, prescribe no more than the expected duration of severe pain requires, and pair medication decisions with close follow-up and patient education. The goal is not “never prescribe.” The goal is “prescribe intentionally.” That sounds obvious now, but healthcare has learned the hard way that obvious ideas are often the ones ignored first.

For chronic pain, the picture gets messy fast

Chronic pain is where cognitive dissonance becomes a full-time tenant. Long-term opioid therapy has weaker evidence for durable benefit than many people assume, especially when the outcome is not just pain score reduction but improved function, daily living, sleep, and quality of life. At the same time, the risks rise with longer exposure and higher doses. So a clinician may face a patient who says, honestly, “This medicine helps me get through the day,” while the literature whispers, “Yes, but at what cost over time?”

The problem is that patients do not live inside journal abstracts. They live inside bodies, jobs, families, and budgets. Some have tried physical therapy, injections, antidepressants, anticonvulsants, mindfulness, heat, ice, braces, stretching, acupuncture, and enough over-the-counter pain relievers to stock a small pharmacy. When they say opioids are the only thing that has helped, they may not be exaggerating. That does not erase the risks. It does explain why the conversation becomes emotionally loaded so quickly.

How policy changed the emotional weather of prescribing

Medicine swung from liberal prescribing to guarded prescribing

The United States spent years learning painful lessons about aggressive opioid prescribing. That history reshaped guidelines, insurer behavior, pharmacy practices, hospital policies, and clinician psychology. As a result, many doctors now practice in an environment where every opioid decision feels visible, reviewable, and potentially second-guessed. Some of that caution is appropriate. Some of it turns into defensive medicine with a nervous pulse.

Here is the irony: policy corrections designed to reduce harm can create new harms when applied like blunt instruments. A clinician may feel pressure to cut doses quickly, deny continuation without individualized review, or avoid taking over care for a patient already using long-term opioids. That is not careful medicine. That is fear wearing the costume of safety.

The backlash can produce a second contradiction

When opioid prescribing tightened, the intended message was not “pain does not matter.” Yet many patients heard exactly that. Some were rapidly tapered. Some felt abandoned. Some could not find a new clinician willing to manage existing therapy. Some were treated as if needing pain care and having addiction risk were moral failings instead of medical realities.

This is where the dissonance grows louder. A doctor may believe opioids should be reduced when risks outweigh benefits, while also knowing that abrupt changes can trigger withdrawal, worsening pain, psychological distress, and dangerous destabilization. The same clinician may support prevention and still worry that rigid rules punish patients who did not create the crisis. In other words, the clinician is not torn because they are confused. They are torn because the situation is genuinely conflicted.

The patient experience inside the contradiction

Patients often feel both seen and suspected

For patients with legitimate pain, opioid conversations can feel like entering a courtroom where they must prove they are suffering correctly. They may be asked detailed questions, sign agreements, undergo prescription monitoring checks, submit toxicology screening, and defend why they need relief at all. Some understand the safety logic. Others hear a subtler message: “We believe your pain might be real, but we also think you might be the problem.”

That emotional split is corrosive. Trust is hard to build when one side feels watched and the other feels liable. A patient may become guarded. A clinician may become skeptical. Then each person misreads the other’s anxiety as evidence of bad intent. Congratulations: everyone is now miserable, and nobody’s back pain has improved.

Language matters more than people think

Even the words around opioid care can deepen the problem. Terms like “drug-seeking,” “clean,” “dirty,” or “narcotics contract” can push care into a punitive frame. Better language does not solve every clinical dilemma, but it changes the tone from accusation to collaboration. A patient can be high-risk without being a bad person. A clinician can set boundaries without becoming a jail warden with an electronic health record login.

The clinician experience: moral distress in plain clothes

Every refill can feel like a referendum

Clinicians do not just weigh pharmacology. They weigh uncertainty, policy, liability, time pressure, patient history, comorbid mental health conditions, family dynamics, and the possibility that one decision could either improve someone’s life or start a spiral. That is a lot to fit into a fifteen-minute visit and an inbox already screaming for attention.

Some clinicians worry about causing addiction. Others worry about under-treating pain. Many worry about both at once. The result is moral distress: the sense that no available option is clean, and that whichever path you choose will leave something important unprotected.

Documentation can become emotional armor

One side effect of this dissonance is excessive defensive documentation. Charts become packed with cautionary language, checklists, and disclaimers. Some of that is clinically useful. Some of it is psychological self-defense. It allows clinicians to say, in effect, “I know this decision is risky, but please see that I worried about it very carefully.” That may protect the chart. It does not always protect the relationship.

What better opioid prescribing looks like

Start with honesty, not ideology

Better care begins when clinicians stop pretending opioids are either heroes or villains. They are tools. Sometimes important tools. Sometimes the wrong tools. The real question is whether benefits are likely to outweigh risks for this patient, in this condition, at this moment, with this level of monitoring and this set of alternatives.

That means discussing realistic goals before starting or continuing therapy. Not “Will this erase pain forever?” but “Will this improve sleep, walking, work tolerance, or basic daily function enough to justify the risks?” Functional goals are less dramatic than miracle promises, but they are more useful and much less likely to ghost you later.

Use safety measures without turning care into punishment

Good prescribing is not loose. It is structured. It may include immediate-release formulations at initiation, cautious dosing, limited quantities for acute pain, early follow-up, review of prescription monitoring data, attention to sedating co-medications, toxicology testing when appropriate, and offering naloxone when overdose risk is elevated. These steps are not signs of distrust by default. They are signs that the clinician is taking the medication seriously.

But structure works best when it is explained well. Patients do better when monitoring is framed as standard safety practice rather than a personalized suspicion campaign. “We do this because the medication can be risky” lands differently than “We do this because we are worried about you specifically.” Same clinic. Very different emotional weather.

Taper with the patient, not at the patient

When opioids no longer help enough, or when harms begin to outweigh benefits, tapering may be reasonable. The keyword is reasonable. A patient-centered taper is collaborative, measured, and responsive to what the patient is experiencing. It is not a dramatic gesture designed to make a guideline look satisfied by Friday afternoon.

The best clinicians prepare patients for the emotional side of tapering as much as the physical side. They add other pain strategies, support sleep and mood, watch for withdrawal, discuss overdose risk if tolerance drops, and keep the relationship intact. The message should be: “We are changing the plan, not abandoning you.” That sentence alone can lower the temperature in a room by ten degrees.

The bigger truth: pain care and addiction care should not be enemies

One of the strangest features of the opioid era is how often pain care and addiction care are treated like rival camps fighting over the same microphone. In reality, both are forms of harm reduction. Both are forms of dignity preservation. Both require evidence, humility, and human communication that does not sound like it was written by a liability committee.

The cognitive dissonance of prescribing opioids is not a sign that medicine has failed to think clearly. It is a sign that clinicians are trying to hold two moral imperatives at the same time: reduce suffering and prevent harm. The answer is not to pick one and ignore the other. The answer is to tolerate complexity without becoming cynical, rigid, or careless.

That is harder than writing a prescription. It is also harder than refusing one. But it is the work. And if medicine is serious about doing better, it must stop asking clinicians and patients to choose between compassion and caution. Good care demands both.

Experiences related to the cognitive dissonance of prescribing narcotics

The experiences below are written as composite, real-world style scenarios based on common themes in American pain care and opioid prescribing.

A family physician opens the chart before the patient walks in and already feels the tension. The medication list is long, the pain history is longer, and the refill request has arrived with three portal messages and one note from the pharmacy. The patient is polite, tired, and frustrated. She says the medication is the difference between functioning and falling apart. The physician believes her pain is real. He also knows the dose is higher than he likes, the evidence for long-term benefit is limited, and the combination with another sedating medication makes him uneasy. So he enters the room carrying two truths that do not sit comfortably together: “I want to help,” and “I am worried my help may hurt.”

Meanwhile, the patient is having her own version of the same conflict. She hates needing the medication. She hates even more that the medication is the only thing that has kept her working enough hours to pay rent. She can feel the clinician’s caution and interprets it as doubt. Now she is trying to describe pain clearly without sounding dramatic, responsible without sounding rehearsed, and desperate without sounding manipulative. It is a miserable performance, especially because she never asked to audition for it in the first place.

In a surgical clinic, another version plays out. A patient after a difficult operation wants reassurance that he will not be sent home to “just tough it out.” The surgeon wants to control severe short-term pain but also wants to avoid starting a pattern that extends far beyond the healing window. The conversation goes better when the surgeon explains the plan plainly: what the opioids are for, how long they are expected to be useful, what side effects matter, what non-opioid tools will be used alongside them, and what follow-up will look like. The cognitive dissonance does not vanish, but it becomes manageable because the uncertainty is shared instead of hidden.

At the pharmacy counter, the contradiction can feel even harsher. A patient who has taken the same medication for years is told the prescription needs clarification, prior authorization, or partial filling. The pharmacist is not trying to be cruel. The pharmacist is trying to practice safely within regulations, stock limits, and risk systems that do not know the patient as a person. Still, the patient experiences the delay as humiliation. What looks like a workflow problem to the system can feel like moral judgment to the person standing at the register with pain and a paper bag of groceries.

Families feel it too. A spouse may want their loved one’s pain treated, but fear overdose, sedation, falls, or a slow change in personality. Parents may lock up medications while still wanting the patient to have access. Adult children may wonder whether asking questions will sound unsupportive. In homes like these, opioids are rarely just pills. They become symbols of hope, fear, dependence, relief, risk, and the quiet question nobody likes to ask out loud: “Are we helping, or are we getting in deeper?”

Perhaps the most revealing experience is the one in which a clinician decides to taper, but does it well. The visit is longer. The explanation is clearer. Alternatives are offered rather than waved at vaguely from across the room. The patient is allowed to be upset without being labeled difficult. The dose changes gradually. The relationship survives. This does not happen because the problem became simple. It happens because both people were treated like adults facing a complicated reality together. That is the real antidote to cognitive dissonance in prescribing: not certainty, but trust.

When opioid care goes badly, both sides feel morally cornered. When it goes well, both sides still feel the weight of the decision, but they are no longer carrying it alone. That difference matters. It may not fit neatly on a pain scale from zero to ten, but it can determine whether treatment becomes a pathway to stability or another chapter in the long American story of pain, policy, and unintended consequences.

Final note: This article is for informational purposes only and is not medical or legal advice.